Neurotech Pharmaceuticals, Inc., a private biotech company focused on developing transformative therapies for chronic eye ...

Beth Marsh will lead commercialization for Neurotech, which gained FDA approval for its eye disease therapy. Neurotech in May ...

See α-Synuclein. Candidate tracer SY08 detects α-synuclein deposits in the brainstem (right) and parietal cortex (left) of ...

What is Parkinsonism? Parkinsonism is a neurological disorder that affects the movement of the body. It is named after James ...

mayo.edu Idiopathic intracranial hypertension (IIH ... Of the eight with persistent visual symptoms, at least five were noted to have optic atrophy prior to stent placement. Only 41 patients who ...

Primary dysautonomia also describes when functions regulated by the ANS fail for no known reason (referred to as idiopathic dysautonomia ... The disorder may progress and lead to multiple symptom ...

Despite significant advancements in spinal muscular atrophy (SMA) management, unmet needs persist, especially for patients ...

When breathing becomes increasingly difficult with no clear explanation, idiopathic pulmonary fibrosis (IPF) might be the culprit behind the concerning symptoms. This rare yet devastating lung ...

Experts discuss how to evaluate and communicate the return on investment for continuous glucose monitoring (CGM) coverage to overcome cost-related barriers, explore strategies other payers could ...